USPTO serial 88564669
DFDA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- EUBANK, REBECCA A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DFDA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Francis John Ciaramella, Esquire
Francis John Ciaramella, Esquire Francis John Ciaramella, PLLC110 Front Street, Suite 300Jupiter, FL 33477UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Dosage formulation development and analysis services, namely, pharmaceutical drug development services, testing services for pharmaceuticals, pharmaceutical products development, laboratory research services relating to pharmaceuticals, and testing, inspection or research of pharmaceuticals; Dosage formulation in the nature of pharmaceutical drug development services, pharmaceutical products development using Multi-Factor-At-a-Time strategies; Dosage formulation and analysis in the nature of pharmaceutical drug development services, pharmaceutical products development, and testing services for pharmaceuticals, namely, developing different dose and delivery systems in the nature of oral solids in the nature of tablets, capsules, gummies, candy, pastes, powder blends, oral semi-solids in the nature of soft-gels, gels in the nature of oral liquids, tincture, syrup, sprays, sublingual sprays, and oral care liquids, vitamins, mineral drinks, and topical formulations in the nature of dermal and transdermal creams, gels, lotions, and serums; Scientific research services in the nature of qualitative and quantitative analysis of key active compounds in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products; Pharmaceutical research services in the nature of dosage and dose analysis in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify potency and strength of dosage; Scientific research services in the nature of forced degradation analysis of pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify stability indication of the dosage and the shelf life determination | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 3, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 4, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 4, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 21, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 21, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 21, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 21, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 21, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 21, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 2, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |